Efficacy and safety of second-generation long-acting injections in schizophrenia: a meta-analysis of randomized-controlled trials

@article{FusarPoli2013EfficacyAS,
  title={Efficacy and safety of second-generation long-acting injections in schizophrenia: a meta-analysis of randomized-controlled trials},
  author={P. Fusar-Poli and M. Kempton and R. Rosenheck},
  journal={International Clinical Psychopharmacology},
  year={2013},
  volume={28},
  pages={57–66}
}
The aim of the present article is to test at a meta-analytical level the efficacy and safety of second-generation long-acting antipsychotic injections (SGLAI) in schizophrenia. Thirteen randomized-controlled trials comparing SGLAI with either placebo or oral antipsychotics were included in a quantitative meta-analysis (6313 patients). Efficacy and safety measures as well as demographic and clinical variables were extracted from each publication or obtained directly from authors. Publication… Expand
Comparative Efficacy and Safety of Long-acting Injectable and Oral Second-generation Antipsychotics for the Treatment of Schizophrenia: A Systematic Review and Meta-analysis
  • Seon-Cheol Park, M. Choi, +10 authors Seung-Hwan Lee
  • Medicine
  • Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology
  • 2018
Long-acting injectable risperidone and oral antipsychotics in patients with schizophrenia: results from a prospective, 1-year, non-interventional study (InORS)
  • A. Schreiner, A. Svensson, +4 authors M. Zink
  • Medicine
  • The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
  • 2014
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 52 REFERENCES
How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials
A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia.
Long-acting injectable risperidone: efficacy and safety of the first long-acting atypical antipsychotic.
Second-generation antipsychotic long-acting injections: Systematic review
...
1
2
3
4
5
...